NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
6.37
-0.27 (-4.07%)
At close: Sep 15, 2026, 4:00 PM EDT
6.52
+0.15 (2.35%)
After-hours: Sep 15, 2026, 7:30 PM EDT
NextCure Market Cap
NextCure has a market cap or net worth of $29.16 million as of September 15, 2026. Its market cap has increased by 101.93% in one year.
Market Cap
29.16M
Enterprise Value
13.74M
1-Year Change
101.93%
Ranking
Category
Stock Price
$6.37
ChartMarket Cap Chart
Since May 9, 2019, NextCure's market cap has decreased from $436.51M to $29.16M, a decrease of -93.32%. That is a compound annual growth rate of -30.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2026 | 29.16M | -41.39% |
| Dec 31, 2025 | 49.74M | 130.37% |
| Dec 31, 2024 | 21.59M | -32.12% |
| Dec 29, 2023 | 31.81M | -18.77% |
| Dec 30, 2022 | 39.16M | -76.37% |
| Dec 31, 2021 | 165.76M | -44.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 9, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Filana Therapeutics | 37.32M |
| Karyopharm Therapeutics | 36.52M |
| Aligos Therapeutics | 32.60M |
| Kyntra Bio | 32.27M |
| Context Therapeutics | 32.19M |
| BriaCell Therapeutics | 31.61M |
| BeyondSpring | 31.42M |
| Quince Therapeutics | 30.05M |